Isla Pharmaceuticals

Island Pharmaceuticals is a mid-clinical stage drug research and repurposing company focused on the rapid development of antiviral therapeutics for infectious diseases. The company targets viral infections such as dengue, Zika, yellow fever, West Nile, and chikungunya. By repurposing existing drugs, Island Pharmaceuticals aims to expedite the development process, reducing time and cost compared to traditional drug discovery methods. The company's primary clients include healthcare providers, pharmaceutical companies, and governmental health agencies. Operating in the pharmaceutical and biotechnology market, Island Pharmaceuticals generates revenue through licensing agreements, research grants, and potential priority review vouchers from regulatory agencies. The business model is centered on leveraging existing compounds to address unmet medical needs in viral infections, thereby providing a faster route to market for effective treatments.

Keywords: antiviral therapeutics, drug repurposing, infectious diseases, dengue, Zika, yellow fever, West Nile, chikungunya, clinical stage, pharmaceutical.